Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Sigma Planning Corp trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 8.7% during the third quarter, according to its most recent disclosure with the ...
Vertex Pharmaceuticals (NASDAQ: VRTX) has stood out over the past several years as a top biotech player, thanks to its work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback